Description
Bevacizumab Injection
Bevacizumab is a monoclonal antibody that selectively targets the factor that is responsible for tumor growth.
Bevacizumab is a monoclonal antibody that inhibits angiogenesis by targeting vascular endothelial growth factor (VEGF). It is used in the treatment of various cancers, including colorectal, lung, breast, and kidney cancers. Additionally, bevacizumab may be employed to manage certain eye conditions such as macular degeneration.